Targeted silencing of CXCR4 inhibits epithelial-mesenchymal transition in oral squamous cell carcinoma.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Oncology Letters

• Publication date

  2016-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/OL.2016.4838PMID 27602138PMCID PMC4998519
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis

  2016cited by this paper
• CXCL12-CXCR4 Axis Promotes Proliferation, Migration, Invasion, and Metastasis of Ovarian Cancer

  2015cited by this paper
• Chemokine receptor CXCR4 and its ligand CXCL12 expressions and clinical significance in bladder cancer.

  2015cited by this paper
• Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.

  2015cited by this paper
• Multilayer control of the EMT master regulators

  2014cited by this paper
• The SDF-1/CXCR4 axis induces epithelial–mesenchymal transition in hepatocellular carcinoma

  2014cited by this paper
• High CXC chemokine receptor 4 expression is an adverse prognostic factor in patients with clear-cell renal cell carcinoma

  2014cited by this paper
• The Effect of CXCR4 Silencing on Epithelial‐Mesenchymal Transition Related Genes in Glioma U87 Cells

  2013cited by this paper
• Epithelial to mesenchymal transition in head and neck squamous cell carcinoma.

  2013cited by this paper
• Lymph node density in oral cavity cancer: results of the International Consortium for Outcomes Research

  2013cited by this paper
• Cancer statistics, 2012

  2012cited by this paper
• Involvement of CXCR4 Chemokine Receptor in Metastastic HER2-Positive Esophageal Cancer

  2012cited by this paper
• RNAi targeting CXCR4 inhibits tumor growth through inducing cell cycle arrest and apoptosis.

  2012cited by this paper
• CD133+CXCR4+ colon cancer cells exhibit metastatic potential and predict poor prognosis of patients

  2012cited by this paper
• Metastasis from oral cancer: an overview.

  2012cited by this paper
• SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway.

  2012cited by this paper
• CXCL12 (SDF1α)-CXCR4/CXCR7 Pathway Inhibition: An Emerging Sensitizer for Anticancer Therapies?

  2011cited by this paper
• Blockade of CXCR4 in oral squamous cell carcinoma inhibits lymph node metastases.

  2011cited by this paper
• Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression

  2010cited by this paper
• Global epidemiology of oral and oropharyngeal cancer.

  2009cited by this paper
• Epithelial-mesenchymal transitions in development and disease.

  2009cited by this paper
• The chemokine receptor CXCR4 is expressed in pancreatic intraepithelial neoplasia

  2008cited by this paper
• Metastasis of squamous cell carcinoma of the oral tongue

  2007cited by this paper
• CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment.

  2006cited by this paper
• Epithelial-to-mesenchymal transition confers resistance to apoptosis in three murine mammary epithelial cell lines.

  2006cited by this paper
• Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression.

  2005cited by this paper
• The clinicopathological significance of the expression of CXCR4 protein in oral squamous cell carcinoma.

  2004cited by this paper
• Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma.

  2003cited by this paper
• Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.

  2002cited by this paper
• The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor Beta in fetal rat hepatocytes.

  2002cited by this paper
• Involvement of chemokine receptors in breast cancer metastasis

  2001cited by this paper
• CXCR4: chemokine receptor extraordinaire

  2000cited by this paper
• The biology of chemokines and their receptors.

  2000cited by this paper
• The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

  1996cited by this paper
• The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

  1996cited by this paper
• Is the guinea pig a full negative model to study the carotid body mediated Chronic Intermittent Hypoxia effects

  1983cited by this paper

• Materials design of gas-releasing nanoplatforms: strategies for precision delivery in oral healthcare

  2025cites this paper
• Triazole-quinoxaline attenuates epithelial-to-mesenchymal transition by suppressing the Wnt/β-catenin pathway in human colorectal cancer cells.

  2025cites this paper
• Molecular Crosstalk between the Immunological Mechanism of the Tumor Microenvironment and Epithelial–Mesenchymal Transition in Oral Cancer

  2022cites this paper
• Oxymatrine suppresses oral squamous cell carcinoma progression by suppressing CXC chemokine receptor 4 in an m6A modification decrease dependent manner.

  2022cites this paper
• Role of chemokine systems in cancer and inflammatory diseases

  2022cites this paper
• Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis

  2022cites this paper
• Drug Delivery Systems in the Development of Novel Strategies for Glioblastoma Treatment

  2022cites this paper
• Bioinformatics analysis reveals that ANXA1 and SPINK5 are novel tumor suppressor genes in patients with oral squamous cell carcinoma

  2021cites this paper
• MiR‐32‐5p promoted epithelial‐to‐mesenchymal transition of oral squamous cell carcinoma cells via regulating the KLF2/CXCR4 pathway

  2021cites this paper
• Tumor‐associated neutrophils (TANs) in human carcinoma‐draining lymph nodes: a novel TAN compartment

  2021cites this paper
• Inhibition of ITGB1 enhance the anti-tumor effect of cetuximab in colorectal cancer cell

  2020cites this paper
• ALDH3A1 acts as a prognostic biomarker and inhibits the epithelial mesenchymal transition of oral squamous cell carcinoma through IL-6/STAT3 signaling pathway

  2020cites this paper
• CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer

  2020cites this paper
• Epithelial‐to‐mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities

  2020cites this paper
• Effects of insulin-like growth factor binding protein 3 on cell growth and tumorigenesis in oral squamous cell carcinoma

  2019cites this paper
• Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.

  2019cites this paper
• CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy.

  2019cites this paper
• Pathological roles of the homeostatic chemokine CXCL12.

  2018cites this paper
• RNA interference: new mechanistic and biochemical insights with application in oral cancer therapy

  2018cites this paper
• CXCR4/CXCR7/CXCL12-Axis in Follicular Thyroid Carcinoma

  2018cites this paper
• CXCR4 enhances cisplatin resistance of human tongue squamous cell carcinoma

  2018cites this paper
• The CXCL12 (SDF-1)/CXCR4 chemokine axis: Oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy.

  2018cites this paper
• Altered Immune-Related Gene Expressions Indicate Oral Cancer Nodal Disease

  2018cites this paper
• The N-terminal polypeptide derived from viral macrophage inflammatory protein II reverses breast cancer epithelial-to-mesenchymal transition via a PDGFRα-dependent mechanism

  2017cites this paper
• CXCR4: A New Player in an Old Scene?

  2017cites this paper